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 Behavioral abnormalities exhibited by reelin deficient mice may model behavioral 
deficit characteristics that are associated with schizophrenia, bipolar disorder, autism, 
and/or attention deficit hyperactivity disorder (ADHD). To expand upon the behavioral 
phenotype of reelin deficient mice,  the effects of methylphenidate (MPH) and nicotine 
(NIC) were evaluated on specific behaviors in homozygous (rl/rl, 100% deficient), 
heterozygous (+/rl, 50% deficient), and wild-type (+/+, 0% deficient) mice to determine 
if drugs would differentially influence behavior depending on level of reelin deficiency, 
and to determine if responses to drug treatments modeled effects that would be predicted, 
assuming mice modeled impairments associated with schizophrenia, bipolar disorder, 
autism, or ADHD. In addition, NIC and saccharin vehicle (S-VEH) intake lev ls were 
measured to determine if mice self-administer NIC differently depending on genotype. A 
non-linear gene dosage effect of NIC, but not MPH, was observed in prepulse inhibitio  
(PPI), such that NIC improved PPI in +/+ and rl/rl mice, while NIC tended to reduce 
abnormally elevated startle response and PPI in +/rl mice. During NIC self-
administration trials, +/rl mice decreased NIC intake when concentration of NIC  
increased to 60 mg/kg/BW, while rl/rl mice tended to increase NIC intake with increased 
NIC concentration. Moreover, +/rl and rl/rl mice exhibited elevated levels of S-VEH 
intake, and rl/rl mice exhibited an intensified fluid dispenser side bias compared to +/+ 
mice. In tests of social interaction, rl/rl mice displayed impaired social recognition. In 
 
 
 
 
 
addition, NIC +/rl mice exhibited increased social behavior, while NIC rl/rl mice 
displayed decreased social behavior. In the passive avoidance (PA) test, allgenotypes 
demonstrated the ability to withhold a response—which is a measure executive 
functioning—and rl/rl mice demonstrated enhanced performance. In addition, MPH 
produced enhanced performance in +/rl mice and rl/rl compared to VEH condition. Thus, 
behavioral outcomes and pharmacological responses in the present study expand upon 
profiles of +/rl and rl/rl mice, offer guidance about which behaviors across and/or within 
diagnostic categories may be most profitably modeled by behavioral features of these 
mice, and may provide insight into underlying neurobiological pathology associated with 
altered cholinergic and dopaminergic pathways as a consequence of disrupted reelin 
production.  
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CHAPTER I 
 
INTRODUCTION 
 
 
 Animal models of neurodevelopmental disorders provide opportunities to 
investigate biological mechanisms of abnormal behaviors. However, although 
neurodevelopmental disorders are classified by distinct diagnostic criteria, specific 
behavioral impairments may transcend diagnostic categories. In addition, the degre  of 
impairment may vary across subtypes within diagnostic categories. Thus, recent 
directions in research involve the identification of animal models of shared behavioral 
impairments across and within subtypes of diagnostic categories (Geyer, 2006; Tordjman 
et al., 2007) to unravel structure–function relationships of behavioral impairments in 
neuropsychiatric disorders. In this approach, using animal models to gain knowledge of 
both shared and non-shared structure–function relationships may advance efforts to 
determine neurobiological targets for preventive strategies and interventions via 
pharmacological treatments in specific behavioral domains. Thus, in the present study, 
the pharmacological effects of methylphenidate (MPH) and nicotine (NIC) on the 
behavioral phenotype of reelin deficient mice were investigated in the context f 
behavioral domains that are relevant to schizophrenia, bipolar disorder, autism, and 
ADHD. 
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Reelin Deficits and Abnormal Neurobiology in Mice and Patient Populations  
 Reelin, an extracellular matrix protein (RELN), plays a key role in neuronal 
migration (D'Arcangelo et al., 1995) and a putative role in neural plasticity in adulthood 
(see review, Levenson, Qiu, & Weeber, 2008). Disruption of reelin pathways and 
abnormal neurobiology of reelin deficient mice bear similarities to abnormalities reported 
in neuropsychiatric populations. For example, the absence of reelin in homozygous reelin 
mutant mice (rl/rl) (D'Arcangelo et al., 1995) and reduced (~50%) levels of reelin in 
heterozygous reelin deficient mice (+/rl) (Costa et al., 2001) mirror deficiencies of reelin 
that have been reported in individuals with autism (up to ~80%), schizophrenia (~50%), 
and bipolar disorder (~50%) (Fatemi, Earle, & McMenomy, 2000). Reelin deficient mice 
also exhibit neuroanatomical anomalies, such as reduced dendritic branching (Pappas, 
Kriho, & Pesold, 2001), which bear similarities to neurodevelopmental abnormalities 
found in brains of individuals with schizophrenia, bipolar disorder (Costa et al., 2001), 
and autism (Pardo & Eberhart, 2007). Central to the pharmacological focus of the present 
study are reports of altered pathways involving the neurotransmitters acetylcholine (ACh) 
and dopoamine (DA) in reelin deficient mice (Tueting et al., 1999) and individuals with 
schizophrenia (Freedman, Hall, Adler, & Leonard, 1995; Stone, Morrison, & Pilowsky, 
2007), bipolar disorder (Torrey et al., 2005), autism (Pardo & Eberhart, 2007), and 
ADHD (Kuntsi, McLoughlin, & Asherson, 2006).    
  
Cholingergic Abnormalities, Reelin Deficient Mice, and Neuropsychiatric Disorders 
 Acetylcholine is a key excitatory neurotransmitter, and as such, activation of ACh 
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receptors (AChRs) results in increased neural signaling (McKay, Placzek, & Dani, 2007). 
Importantly, abnormalities in ACh pathways have been reported in reelin deficient m ce. 
For example, +/rl mice exhibit reduced cholingergic cell numbers and decreased 
cholinergic innervation in selective areas of the brain (Sigala et al., 2007). In rl/rl mice, 
evidence of elevated expression of acetylcholinesterase (AChE), an enzyme involved in 
the hydrolysis of acetylcholine, suggests reduced availability of acetylcholine in the 
cerebellum and hippocampus (Garcia-Ayllon et al., 2003). Conversely, the absence of 
AChE-positive fibers elsewhere suggests potentially high levels of acetylcholine in other 
areas of the brain in rl/rl mice (Martin, 1981). In addition, prenatal administration of 
AChE blocker in rl/rl mice reversed certain behavioral effects (i.e., ultrasound 
vocalization, amphetamine-induced locomotion, and stereotypy) associated with the 
absence of reelin (Laviola, Adriani, Gaudino, Marino, & Keller, 2006). Thus, reelin 
deficiency appears to be associated with altered AChE and ACh activity, which in turn 
results in behavioral abnormalities.  
 The aforementioned reports of cholinergic abnormalities in reelin deficient mice 
are of particular interest in light of reports of altered ACh pathways in neuropsychiatric 
disorders. For example, altered expression of nicotinic ACh receptors (nAChr) in t e 
hippocampus, frontal cortex, and other areas have been associated with schizophrenia 
(see Reviews, Gotti & Clementi, 2004; Olincy & Stevens, 2007), while under- and over-
expression of nAChr subtypes have been associated with autism (Martin-Ruiz et al., 
2004; Perry et al., 2001).  While ADHD has not been associated with altered reelin 
pathways, it has been associated with altered nAChr expression as well (Pott r, 
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Newhouse, & Bucci, 2006). Importantly, altered ACh pathways in reelin deficient mice 
and in neuropsychiatric patients may be relevant to compromised neural plasticity, 
including disruption of pathways involving other key neurotransmitters. 
 
Dopaminergic Abnormalities, Reelin Deficient Mice, and Neuropsychiatric Disorders 
 Activation of ACh receptors results in indirect excitatory and/or inhibitory 
influences on pathways involving other neurotransmitters, including (but not limited to) 
dopamine (McKay, Placzek, & Dani, 2007). Thus, reports of abnormal dopamine 
functioning in reelin deficient mice are also central to this study. For example, young 
adult +/rl mice exhibit alterations in the mesolimbic dopamine pathway, including 
reduced DA2 receptor mRNA, increased DA3 receptor mRNA levels, and increased D3 
binding sites (Ballmaier, Zoli, Leo, Agnati, & Spano, 2002). Furthermore, since ACh 
receptors are typically present on dopamingergic neurons in the mesolimbic pathway 
(Wooltorton, Pidoplichko, Broide, & Dani, 2003), these findings also suggest possible 
disturbances in ACh functioning. In rl/rl mice, DA transporters are significantly reduced 
(Giompres & Delis, 2005), and the absence of reelin signaling has been associated with a 
reduction of DA receptors and receptor-mediated dopaminergic functions, and with 
reduced methamphetamine-induced hyperlocomotion (Matsuzaki et al., 2007). In 
addition, disruption of reelin in +/+ mice results in reduced methamphetamine-induced 
hyperlocomotion, which suggests that reelin signaling plays a key role in the 
dopaminergic related behavior in adult mice (Matsuzaki et al., 2007).  
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 Altered dopamine functioning has also been reported in individuals with 
schizophrenia, autism, and ADHD. For example, decreased DA activity in the prefrontal 
cortex and increased DA activity in the striatum have been reported in individuals with 
schizophrenia (Stone, Morrison, & Pilowsky, 2007). In autism, recent reports of impaired 
neural synchronization, which relies on signaling mediated by D4 receptor activation, is 
impaired (Deth, Muratore, Benzecry, Power-Charnitzky, & Waly, 2008), and in ADHD, 
altered DA activation and DA transporters have been reported (see review Swanson et al, 
2007). Taken together, evidence of altered neurobiology, including pathways involving 
ACh and DA, in reelin deficient mice and in patient populations, suggests that 
investigation of behavioral impairments in reelin deficient mice may be relevant to the 
development of models for behavioral impairments associated with human disorders such 
as schizophrenia, autism, and ADHD. 
 
Behavioral Abnormalities in Reelin Deficient Mice:  Potential Behavioral Models for 
Human Disorders 
 Behavioral abnormalities exhibited by reelin deficient mice may model cor  
diagnostic criteria and related characteristics for human psychopathology. For example, 
impaired sensorimotor gating, as measured by prepulse inhibition (PPI) of the star le 
response in +/rl mice (Tueting et al., 1999), and deficits in PPI in rl/rl mice (Salinger, 
Ladrow, & Wheeler, 2003) may model impaired PPI associated with schizophrenia, 
bipolar disorder (Perry, Minassian, Feifel, & Braff, 2001), and autism (Perry, Minassian, 
Lopez, Maron, & Lincoln, 2007). Similarly, reports of abnormal social interactions in 
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reelin deficient mice, such as severe impairments in maternal behavior (Salnger, not 
published) and  abnormally dominant behavior for rl/rl mice (Salinger et al., 2003) 
suggest that social behavior in reelin deficient mice may model behavioral impairments 
associated with schizophrenia, bipolar disorder, autism, and ADHD. In addition, reports 
of abnormal response inhibition in reelin deficient mice (Ognibene, Adriani, Granstrem, 
Pieretti, & Laviola, 2007) suggest that these mice may be useful to model impairments of 
executive functioning reported in individuals with schizophrenia, bipolar, ADHD, and 
autism (Russo et al., 2007).  
 Thus, behavioral abnormalities exhibited by reelin deficient mice may model 
behavioral impairments that are observed within and/or across diagnostic categories of 
schizophrenia, bipolar disorder, autism, and ADHD.  If so, reelin deficient mice may 
provide opportunities to delineate abnormal neurobiological mechanisms associated with 
behavioral impairments associated with neuropsychiatric disorders. Therefore, this study 
expanded upon earlier research to further characterize the behavioral phenotypes of reelin 
deficient mice as potential models for behavioral characteristics associ ted with 
schizophrenia, bipolar disorder, autism, and possibly ADHD. To do so, the effects of 
nicotine (NIC), a direct acetylcholine agonist, and methylphenidate (MPH), a direct 
dopamine agonist, were evaluated on measures of sensorimotor gating and learning in 
rl/rl, +/rl and +/+ mice. NIC self-administration and effects of NIC in tests of sociability 
and social recognition (memory) were also evaluated. 
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Pharmacological Manipulations and Behavioral Assays 
 PPI. The first goal of this study was to evaluate the effects of pharmacologi a  
manipulations of prepulse inhibition (PPI) of the startle response. PPI is frequently sed 
to operationally measure sensorimotor gating, or the ability to filter sensory stimuli, 
across different species (Braff, Geyer, & Swerdlow, 2001). In PPI, when a prepulse is 
presented, the size of the startle response that is produced by a loud, startling stimulus 
(e.g.120 dB) is reduced compared to when the startle stimulus occurs without a prepulse. 
This phenomenon is modulated, in part, by dopaminergic (Ballmaier et al., 2001) and 
cholinergic pathways (Swerdlow et al., 2001). Thus, modulation of dopaminergic and 
cholinergic pathways is of particular importance to the pharmacological manipul tions in 
the present study. 
 Methylphenidate (MPH) directly targets DA transporters to increase the 
availability of DA, and as previously discussed, rl/rl and +rl mice exhibit abnormalities 
in pathways involving DA (Giompres & Delis, 2005; Yamashita et al., 2006). In human 
populations, while MPH attenuates some behavioral deficits associated with ADHD, 
MPH exacerbates behaviors that are characteristic of other disorders such as 
schizophrenia (Koreen, Lieberman, Alvir, & Chakos, 1997). Thus, if MPH alters PPI, the 
direction of change in PPI could be informative in terms of reelin deficiency a d 
behavioral impairments associated with neuropsychiatric disorders.  
 Nicotine (NIC), an agonist of acetylcholine, binds to and activates nicotinic 
acetylcholine receptors (nAChRs). Importantly, r /rl and +rl mice exhibit abnormalities 
in pathways involving acetylcholine, and rl/rl mice reliably exhibit impaired PPI 
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(Salinger, Ladrow & Wheeler, 2003; Goode, 2006). In addition, NIC has been shown to 
improve PPI in mice (Ingram et al., 2005). In schizophrenic populations, administration 
of NIC via smoking improves PPI (Postma et al., 2006) and normalizes abstinence-
induced PPI deficits (George et al., 2006). Although effects of NIC on impaired PPI in
individuals with bipolar disorder and autistic populations have not been reported, it has 
recently been suggested that NIC may exert negative effects on individuals with autism 
(Lippiello, 2006). Thus, NIC could normalize PPI abnormalities in rl/rl mice, as it does in 
individuals with schizophrenia. On the other hand, NIC could exacerbate PPI in rl/rl
mice, which would be consistent with ACh-antagonist theories about autism (Lippiello, 
2006). 
 Nicotine self-administration. The second objective of this study was to determine 
if rl/rl, +/rl, and +/+ mice differ in patterns of self-administration of NIC, based in part 
on reports that individuals in the aforementioned diagnostic categories exhibit different 
prevalence rates of smoking. For example, compared to the general population (~25-
30%), people with schizophrenia exhibit higher prevalence rates (67% - 87%) of smoking 
(Poirier et al., 2002; Vanable, Carey, Carey, & Maisto, 2003). Furthermore, severity of 
symptoms and intensity of smoking are positively correlated in schizophrenia (Patk r et 
al., 2002). Prevalence rates for bipolar disorder (70%) (Hughes, Hatsukami, Mitchell, & 
Dahlgren, 1986) and ADHD (40%) (Pomerleau, Downey, Stelson, & Pomerleau, 1995) 
are also higher compared to the general population. Conversely, the prevalence rat of 
smoking in autism is low (12.5%) (Bejerot & Nylander, 2003) compared to the general 
population. Although the latter observation could be reflective of limited access to 
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cigarettes, Lippiello (2006) theorizes that, based on evidence of neuroanatomical 
abnormalities with potential hypercholinergic consequences, individuals with autism may 
actively avoid NIC. Thus, in the present study, if rl/rl, +/rl, and +/+ mice displayed 
differences in NIC self-administration, outcomes may be informative in trms of potential 
relationships between reelin deficiency NIC, the degree of nicotine abuse, and reelin-
related pathologies (i.e., schizophrenia, bipolar disorder, autism) as well as ADHD.  
 Social interactions. The third objective of this study was to determine if rl/rl and 
+/rl mutant mice exhibit abnormalities in social activity.  The rationale for this assay was 
based, in part, on similarities in reelin disruption between reelin deficient mice and 
individuals with disorders that are characterized by reelin disruption and abnormal social 
behavior. In addition, the relationship, if any, between degree of reelin deficiency and the 
severity and direction of social impairment was also of interest based on the 
heterogeneity in social impairment observed in schizophrenia, bipolar disorder, an  
autism. For example, although schizophrenia is characterized by poor social skills and/or 
social withdrawal, schizoaffective subtypes of schizophrenia may display more outgoing 
behavior during manic-like episodes (American Psychiatric Association, 2000). 
Similarly, individuals with bipolar disorder may exhibit social withdrawal during 
depressive episodes; however, during manic episodes, the opposite may be observed 
(American Psychiatric Association, 2000). Conversely, autism is characterized by a 
profound lack of sociability (American Psychiatric Association, 2000).  Thus, models to 
elucidate neurobiological and behavioral components that underlie the heterogeneity of 
social impairment within and across diagnostic categories may be useful.   
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 Animal models involving attention and responsiveness to social cues may be 
useful to model social impairments, based on reports that individuals with autism and 
schizophrenia differ in orienting responses to social stimuli (Sasson et al., 2007). In 
addition, nicotine has been reported to enhance social memory in mice (Manrique, 
Miquel, & Aragon, 2005). Thus, the effect of NIC on mice in tasks dependent on socially 
relevant cues was evaluated in a modified version of a behavioral assay designe  to 
evaluate social activity (Crawley, 2004). In the modified paradigm, if micespend more 
time with a novel non-social stimulus (inanimate object) compared to a novel social 
stimulus (stranger mouse), they model diminished social behavior. In the subsequent trial, 
if mice spend more time with a mouse to which they have had recent exposure (familiar 
mouse) compared to a novel social stimulus (new stranger mouse), or if they exhibit no 
preference between social stimuli, the lack of normal preference for novel social timuli 
reflects impaired social recognition (memory).     
 Passive avoidance (PA). The fourth objective of this study was to assess 
executive functioning of reelin deficient mice in an assay that requires animals to learn an 
association between a response (moving from a light chamber into a dark chamber) and 
an aversive stimulus (mild foot shock delivered if animal enters dark chamber). This test 
measures emotional learning and memory, and the ability to withhold the response whe 
exposed to the chamber during the second trial. In previous studies conducted in this lab 
(Goode, 2006), reelin deficient mice tended to exhibit decreased latency (compared to 
+/+ mice) to enter the dark chamber (where previously shocked). Furthermore, Ognibene 
et al. (2007) recently reported that +/rl mice exhibited an inability to inhibit motor 
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responses in operant conditioning. Taken together, these findings suggest that reelin 
deficiency in mice may be associated with deficits of executive functioning.  
   Importantly, PA is, in part, modulated by DA (Ichihara, Nabeshima, & 
Kameyama, 1988), and MPH, a direct agonist of DA, has been reported to improve 
performance on tasks that require response inhibition in humans (Aron, Dowson, 
Sahakian, & Robbins, 2003). However, nicotinic acetylcholine receptors (nAChRs)—
which are important for processes involved in learning and memory—appear to play a 
role in normal performance in the passive avoidance as well (King et al., 2003; Picciotto 
et al., 1995). Furthermore, this assay has been shown to be sensitive to the effects of NIC 
such that NIC can enhance passive avoidance learning in adult wild-type mice (King et 
al., 2003). Thus, both MPH and NIC effects were assessed on performance in the passive 
avoidance test. 
 
Summary of Predictions  
 Pharmacological manipulations of prepulse inhibition (PPI). MPH was not 
predicted to improve PPI. In addition, if MPH exacerbated performance, as other direct 
dopamine agonists do, then PPI deficits of reelin deficient mice could potentially model 
schizophrenia (Geyer, Krebs-Thomson, Braff, & Swerdlow, 2001; Koreen et al., 1997). 
 NIC was predicted to enhance normal PPI in +/+ and +/rl mice, and normalize 
impaired PPI in rl/rl mice. If so, PPI response to NIC in rl/rl mice may model NIC 
attenuation of PPI deficits in individuals with schizophrenia (Postma et al., 2006). If 
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however, NIC exacerbated PPI deficits, mice may more appropriately modelautism 
(Lippiello, 2006).  
 Self-administration of nicotine. If NIC intake levels were elevated and/or if levels 
increased over time compared to +/+ mice, then NIC self administration in reelin 
deficient mice may model abnormally high nicotine consumption exhibited by 
individuals with schizophrenia (Poirier et al., 2002; Vanable et al., 2003), bipolar 
disorder (Hughes et al., 1986) and/or ADHD (Pomerleau et al., 1995). If mice exhibitd 
lower NIC intake levels and/or decreased NIC intake over time compared to +/+ mice, 
then they would be viewed more appropriately as avoiding NIC as do individuals with 
autism (Bejerot & Nylander, 2003). 
 Social interaction paradigm. If mice displayed a preference for an inanimate 
stimulus versus a social stimulus, they would exhibit decreased sociability (Crawley, 
2004), as do individuals with schizophrenia and autism (American Psychiatric 
Association, 2000). If mice displayed a preference for a recently-familiar social stimulus 
versus a novel social stimulus, they would model a lack of normal preference for novel 
social stimuli or be displaying social recognition/memory deficits associated with 
schizophrenia or autism (Crawley, 2004). In addition, if NIC enhanced social memory 
(Manrique et al., 2005), then improved performance may mirror NIC-enhanced cognitive 
functioning associated with schizophrenia. However, if NIC diminished performance, the 
findings may more appropriately support theories associated with autism (Lippiello, 
2006). 
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 Pharmacological manipulations of passive avoidance (PA). MPH improves 
performance on tasks that require response inhibition in individuals with ADHD (Aron et 
al., 2003). Therefore, if reelin deficient mice exhibited inferior learning in PA, and if 
MPH improved passive avoidance performance, then mice would model impaired 
inhibition associated with ADHD. If, on the other hand, MPH exacerbated PA 
performance deficits, the effects of MPH on PA performance of reelin deficient mice 
would model MPH effects on cognitive performance in individuals with schizophrenia 
(Koreen et al., 1997). 
 NIC was predicted to enhance cognitive performance in the passive avoidance test 
(King et al., 2003). If mice exhibited impaired PA learning, and if NIC enhanced 
performance of +/rl mice, then NIC effects on PA performance of +/rl mice would 
model NIC effects on executive functioning deficits associated with schizop renia and/or 
ADHD. If NIC exacerbated PA performance, NIC effects on PA performance of reelin 
deficient mice would support theories related to autism (Lippiello, 2006). 
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CHAPTER II 
 
METHOD 
 
 
Subjects 
 
 Experimentally naïve mice (B6C3FE strain, Jackson Laboratories, Bar Harbor, 
Maine, U.S.A.), bred in our animal colony, were utilized for the behavioral assessment . 
Mice were weaned at 21 days or at body weight of 10–12 grams, whichever came later 
and were housed socially, in same-sex groups of 2-4 littermates. A 10/14 hour lights-on/ 
lights-off schedule at a constant room temperature of ~23°C was maintained. Rat chow 
and water were available ad libitum before and after all of the experiments. The mice 
were between 3-6 months of age at the beginning of assessment procedures. Two cohorts 
of mice were tested (see Table 2). In the first cohort of mice (n = 60), approximately half 
of the mice of each genotype and gender were assigned to either MPH or VEH 
conditions. Testing of the second cohort (n = 95) followed upon completion of testing for 
MPH mice, and approximately half of the mice of each genotype and gender were 
assigned to either NIC or VEH. All experiments were conducted between 1100h and 
1700h in a testing laboratory with lighting and room temperature conditions similar to 
those of the vivarium. The procedures for all paradigms were approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of North 
Carolina at Greensboro. 
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Drugs and Methods of Administration 
 MPH preparation for gavage administration (PPI and Passive avoidance trials). 
MPH (30 mg) was dissolved in 2 ml in tap water (VEH) and administered 30 minutes 
prior to trials by gavage at a dose of 30 mg/kg/BW. The time of administration of 30 
minutes prior to trials was based on pilot trials. Two methods of administering drug 
treatments to mice for PPI are prevalent in the literature:  Intraperiton al (IP) and 
subcutaneous (SC). Although there is greater bioavailability of a drug in a shorter period 
of time when administered IP or SC, MPH was administered by gavage to minimize 
stress related to repeated injections. Doses used in behavioral studies with mice have 
varied, depending on the experimental design and method of administration, with 
intraperitoneal (IP) doses up to 30 mg/kg/BW (Gainetdinov et al., 1999; Rhodes & 
Garland, 2003; Trinh, Nehrenberg, Jacobsen, Caron, & Wetsel, 2003). Pilot trials 
conducted in this lab (MPH 3, 10, 20, 30 mg/kg/BW) determined 30 mg/kg/BW to be an 
effective dose. 
  NIC preparation for gavage administration for PPI, social activity and PA trials. 
Nicotine (NIC) -(-) NIC Hydrogen tartrate (Sigma), 3 mg and 6 mg, was dissolved in 1 
ml tap water (VEH)  and administered 20 minutes prior to trials by gavage at doses of 3 
mg/kg/BW or 6 mg/kg/BW. In previous studies, time of administration prior to testing 
varied from no time delay to 15 minutes prior to testing. Whereas IP and SC injections 
result in shorter latency of bioavailability, oral and gastric administration reported in 
other types of drug studies indicate that longer time periods between dosing and 
behavioral trials may be necessary to maximize bioavailability (Petersen, Norris, & 
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Thompson, 1984; Svensson, 1987). All mice in NIC condition received both 3 mg and 6 
mg NIC and order of administration was counterbalanced; however, no order effects o  
treatment were detected, and 3 mg/kg/BW trials yielded non-significant results (data not 
shown) and thus, are not included in results or discussion.  
 NIC preparation for self-administration trials. Nicotine (NIC) -(-) NIC 
Hydrogen tartrate (Sigma) was dissolved saccharin (0.4%) vehicle (S-VEH), and mice 
were provided with NIC and/or S-VEH solutions for 10 consecutive days (days 1-5 at 
NIC 30 mg/L and days 6-10 at NIC 60 mg/L). The concentration of 30 mgl/L was based 
on methods reported by Adriani, Macri, Pacifici, and Laviola (2002), and the 
concentration of 60 mg/L was based on reports of plasma levels of NIC in mice following 
chronic, oral, ad libitum, self-administration of NIC (60 mg/L) of 34.4 ng/ml (Rowell, 
Hurst, Marlowe, & Bennett, 1983), which is comparable to steady-state levels of about 40 
ng/ml reported in chronic smokers (McNabb, 1984; Russell, Jarvis, Iyer, & Feyerab nd, 
1980).  
 
Behavioral Assays 
   Sequence of behavioral assays. The sequence of trials for all mice was acoustic 
startle response (ASR) and prepulse inhibition (PPI), social activity, passive avoidance 
(PA), and NIC self-administration trials (10 days).  
 Acoustic startle response (ASR) and prepulse inhibition (PPI). Prepulse inhibition 
(PPI) of the acoustic startle response (ASR) measures an unlearned, involuntary reflex 
modulation that is thought to underlie the ability to engage in selective attention (Braff et 
 
 
17 
 
al., 2001). More specifically, when an acoustic prepulse is presented, the size of the 
startle response that is produced by a loud, startling stimulus is reduced compared to 
when the startle stimulus occurs without a prepulse. ASR and PPI were measured using 
the SR-LAB (San Diego Instruments Inc., San Diego, CA) startle response 
measurement system, including software. In this system, a 3.9-cm (outside diameter) 
acrylic cylinder for holding the mouse is mounted on a platform (20.4 cm length X 12.7 
cm width X 0.4 cm thick) with a piezoelectric accelerometer unit attached below the 
acrylic cylinder. The acrylic cylinder and platform are located in a sound attenu ted 
chamber with a loudspeaker (28 cm above the cylinder) and house light. Following a 
modified version of standardized procedures  (Paylor & Crawley, 1997), five acoustic 
stimulus types were presented, with four prepulse stimuli (0, 76, 80, or 84 dB; each 20 ms 
duration) and a startle stimulus (120 dB, 40 ms duration). The 17.39 min. test included a 
5-min acclimation period followed by 10 repetitions of five different trial types and 
intertrial intervals (average 15 s) presented in pseudorandom order. Between-subjects 
variables included genotype, gender, and drug treatment (MPH, NIC, or VEH), and the 
within-subjects variable was prepulse trial type (76, 80, 84 dB). The dependent variables 
were the acoustic startle response (ASR), measured as the amplitude for prepulse 120 dB 
without a prepulse (0 dB), and prepulse inhibition (PPI) of the ASR, expressed as the 
percentage reduction of startle (120 dB) response amplitude when preceded by a 
prepulse:  (Startle amplitude with prepulse – startle amplitude without prepulse / startle 
amplitude without prepulse) X 100. Note:  Although mice were tested with 3 mg/kg/BW 
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NIC as indicated above, no effects of treatment were detected and therefore, only trials 
involving 6 mg/kg/BW are reported and discussed in the results and discussion. 
 Fluid intake in the home cage and fluid side dispenser bias. Total ad libitum fluid 
intake was measured as a control component for NIC self-administration. Mice were 
individually housed and provided with two fluid dispensers in the home-cage. Fluid 
dispensers consisted of 10 ml graduated pipettes that were fitted with stopper from 
standard water bottles. One fluid dispenser was positioned in the typical home-cage (HC) 
location of water bottle placement during non-experimental conditions, and the other 
(novel) fluid dispenser was yoked to the HC pipette, such that it was positioned in the 
opposite side of the cage, relative to the HC fluid dispenser, in the same end of the cage. 
Saccharin vehicle (S-VEH), which consisted of deionized water sweetened with 
saccharin (0.4%), was freshly mixed each morning. S-VEH also served as the base fluid 
to which nicotine was added for NIC-self administration (details below). Fluid mixtures 
and measurements were confirmed and collected each morning by two experimenters, 
and pipettes were rinsed with 70% alcohol, followed by a rinse of deionized water prior 
to replacement of fluids each day. Total S-VEH (ml/kg/BW) and the proportion of S-
VEH intake from each fluid dispenser were the variables of interest as measures of total 
fluid intake and fluid dispenser side bias, respectively. 
 Continuous self-administration with NIC.   For assessment of NIC self-
administration, fluid dispensers were provided as described above for fluid intake i  the 
home cage. Fluids were saccharin vehicle (S-VEH) and nicotine (NIC), and mice were 
assigned to one of three conditions for fluid dispensers in the home-cage (position of 
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pipette novel/HC):  S-VEH/NIC, NIC/S-VEH, S-VEH/S-VEH. For mice with NIC 
choice, fluid dispenser placement was counterbalanced within genotype. Two 
concentrations of NIC (30 mg/L and 60 mg/L dissolved in S-VEH) were presented for 
five consecutive days, with all mice in NIC and S-VEH choice condition receiving NIC 
30 mg/L first, followed by NIC 60 mg/L. The concentrations of NIC (30 mg/L and 60 
mg/L) were based on data reported in pilot studies and on reports that plasma levels of 
NIC in mice following chronic, oral, ad libitum, self-administration of NIC (60 mg/L) 
was found to be 34.4 ng/ml (Rowell et al., 1983), which is comparable to steady-state 
levels of about 40 ng/ml reported in chronic smokers (McNabb, 1984; Russell et al., 
1980). Using both concentrations of NIC allowed mice to demonstrate that they titrated 
the NIC dose to establish optimal levels, since if they were titrating, a switch from the 30 
mg/L to the 60 mg/L NIC solution should cause mice to compensate by reducing 
proportionately the volume of their intake in order to maintain the NIC dosage levels they 
had sustained when self-dosing with the 30 mg/L NIC solution. Only freshly mixed 
solutions of both S-VEH and NIC were used each day, and pipettes were rinsed with 
alcohol, followed by a rinse of deionized water, prior to replacement of fluids. NIC 
(ml/kg/BW) intake and S-VEH (ml/kg/BW) intake were calculated as the difference in 
fluid (ml/kg/BW) from pipettes, as measured and confirmed each day by two 
experimenters prior to refilling pipettes with fresh fluids. 
 The first measure of interest was NIC discrimination, which was operationally 
defined as a significant change in ratio of NIC/total fluids across and/or between 
concentrations. The second measure was the absolute volume of NIC fluid intake 
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(ml/kg/BW). The third measure was S-VEH intake (ml/g/BW) to assess changes in S-
VEH across trials as mice titrated NIC. Finally, NIC self-administration was 
operationally defined as an increase in the proportion of NIC/total fluids compared to the 
expected ratio based on S-VEH/S-VEH control mice within trials of NIC at 30 and 60 
mg/L concentrations.  
 Sociability and social recognition tests. The social recognition test measured the 
tendency of a subject mouse to approach another mouse (compared to a novel object) and 
engage in social investigation. The clear, glass test chamber, 30” long X 12” wide, 
contained three equal-sized zones, separated by two clear, Plexiglas divider walls. In 
Task 1 the subject mouse was placed in the center zone for 10 minutes to acclimate to the 
test chamber. Then, a stranger mouse (S1) of same sex and genotype was placed in eith r 
the left or right end zone in a clear holding cage (5.5” X 6.25” X 3.5”), which contained 
openings for ventilation. The opposite end zone contained an empty cage (EC), which 
was identical to the holding cage for the stranger mouse. Following acclimation, the 
Plexiglas walls were removed and the mouse was allowed to move freely within the tes  
chamber for 10 min. Since rl/rl mice are characterized by motor impairment, and as such, 
could take longer to move from one end of the test chamber to the other, the proportion of 
time in each end zone  was calculated relative to total time in end zones (versus total time 
in zones). The proportion of time in each end zone has been shown to reflect the 
proportion of time investigating each relative target (Crawley, 2004). Sociability was 
defined as spending similar or greater proportion of time with S1 compared to the EC.  
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 In Task 2, which began immediately after completion of Task 1, the test subject 
remained in the test chamber, but S1 was removed and then repositioned in the same 
location when stranger mouse 2 (S2) was placed in the zone/position that was previously 
occupied by the EC. Preference for social novelty was defined as spending 
proportionately more time with S2 compared to S1. Crawley (2004) proposes that in a 
mouse model of impaired social interaction, mice will atypically show equal or less 
investigation of stranger 2 compared to stranger 1, reflecting a lack of normal preference 
for, or recognition of, social novelty. 
 Passive avoidance(PA). The PA test is designed to evaluate learning and memory, 
and to evaluate behavioral inhibition, which is the ability to inhibit responses. Behavioral 
inhibition is a key component of executive functioning (Barkley, 1997). In this study, 
each of two acquisition trial (s) began when the mouse was placed in the left chamber 
(start box) of the PA testing chamber (Coulbourne Instruments, Allentown PA), which
consisted of a shuttle-box apparatus placed within an independent, sound-attenuating 
isolation box of wood construction. After 60 seconds, the guillotine door opened and, if 
the mouse entered the right side of the shuttle box (goal box), the guillotine door closed 
and a mild foot shock (1.0 mA, 2 s duration) was delivered. Mice were eliminated from 
the testing procedures if they failed to enter the right side (300 s maximum latency). The 
test trial, conducted on the following day, consisted of placing the mouse in the star box, 
as in Day 1, to measure latency to enter the goal box (maximum time 300 s). 
 Statistical analyses. All analyses were conducted initially as analysis of variance 
(ANOVA) with between subject factors of genotype (+/+, +/rl, rl/rl), treatment (NIC, 
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MPH, VEH) and gender.  The within-subjects factor was repeated measures cros  
multiple trials. Although hypotheses did not directly address gender effects, previous 
reports suggest that NIC behavioral assessments may be sensitive to gender effects in 
mice (Damaj, 2001), and thus, gender was included in the model. If main effects or 
interactions for gender were not significant, the gender term was removed from analyses. 
However, since the number of mice for each sex for each genotype was small, significant 
effects with gender should be interpreted with caution. In cases of significant interactions, 
additional tests of main effects were conducted either with LSQ (and effect screening) or 
repeated measures.  
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CHAPTER III 
 
RESULTS 
 
 
Acoustic Startle Response (ASR)   
 
 Analysis of the ASR for VEH mice with a three-way ANOVA with genotype 
(+/+, +/rl, rl/rl), gender, and treatment cohort (MPH, NIC) for startle amplitude revealed 
significant main effects of genotype, F(2, 58) = 8.9113, p = .0004, and gender, F(1, 58) = 
6.2870, p = .0150. Consistent with previous findings for genotype, +/rl mice exhibited 
higher startle amplitude at 120dB compared to +/+ and rl/rl mice, and male mice 
exhibited increased startle responses compared to female mice (see Figure 1). In addition, 
there was a significant main effect of group (MPH or NIC), F(1, 58) = 5.5489, p = .0187, 
and a trend for a Genotype X Gender X Group interaction F(2, 58) = 2.6625, p = .0783. 
Effect screening indicated that +/rl VEH mice differed between NIC and MPH treatment 
groups, p = .0316; therefore, to evaluate drug effects, data for +/+ and rl/rl mice were 
analyzed separately from +/rl mice, and +/rl mice groups (MPH, NIC) were individually 
analyzed. However, there were no significant effects of treatment (MPH, NIC) on startle 
amplitude for any genotype.  
 
Prepulse Inhibition (PPI)   
 Consistent with previous findings, PPI performance of VEH mice differed 
depending on genotype, F(2, 54) = 16.1166, p < .001, such that rl/rl mice exhibited 
 
 
24 
 
inferior PPI compared to +/+ and +/rl mice, p < .0001 (see Figure 2a). PPI for +/rl mice 
tended to be superior compared to +/+ mice, p = .0551 (see Figure 2b). In addition, PPI 
for VEH +/rl mice differed between MPH and NIC cohorts, F(1, 24) = 6.0046, p = 
.0219, while PPI for +/+ and rl/rl mice did not; therefore, analyses for treatment effects 
were conducted separately for +/rl mice.   
 For +/+ and rl/rl mice, gender did not contribute to a three-way ANOVA model, 
so gender was removed from the model. Two-way ANOVA with genotype (+/+, rl/rl) 
and treatment (MPH, NIC, VEH) as between-subjects factors and trial type (80, 84 dB) as 
repeated measures indicated  a significant main effect of genotype, F(1, 88) = 36.8544, p
< .0001, with PPI for +/+ mice superior to rl/rl mice, and a significant main effect of 
treatment, F(2, 88) = 3.8853, p < .01, in which PPI for NIC mice was superior to mice in 
VEH and MPH conditions, p < .01. The Genotype X Trial Type interaction, F(1, 88) = 
11.1791, p = .0012, revealed that, regardless of treatment condition, PPI for +/+ mice 
increased with prepulse intensity, while PPI for rl/ l mice did not. The Genotype X 
Treatment interaction was not significant. 
 PPI for MPH +/rl mice did not significantly differ from VEH +/rl mice (data not 
shown), and mice in both conditions exhibited increased PPI with increased dB level, 
F(1, 17) = 6.0719, p = .0247. NIC +/rl mice tended to exhibit inferior PPI compared to 
VEH +/rl mice, F(1, 32) = 4.1363, p = .0503, and PPI increased as dB level increased, 
F(1,32), p < .0001 (see Figure 2b). 
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Total Saccharin Vehicle (S-VEH) Intake  
 S-VEH intake for a control group (S-VEH/S-VEH) mice significantly increased 
across trials, F(3, 21) = 4.2091, p = .0177; however, inspection of Figure 3 indicated that 
increases in volume tended to be due to increased S-VEH by +/rl and rl/rl mice. In 
addition, total S-VEH volume tended to differ between genotypes, F(2, 23) = 2.3590,      
p = .1170, and effect screening indicated that S-VEH intake for +/rl mice was 
significantly greater compared to +/+ mice maintained constant levels of S-VEH intake 
of +/+ mice, p < .05.   
 
Fluid Dispenser Side Bias 
 In mice presented with two S-VEH fluid dispensers (S-VEH/S-VEH), all S-VEH 
mice exhibited a larger proportion of fluid intake from dispensers positioned in the 
standard home-cage (HC) location compared to the novel position, F(1, 23) = 28.0066, p
< .0001, indicating a bias for HC fluid dispensers. In addition, a significant main effect o  
genotype, F(2, 23) = 4.4152, p = .0238, indicated that genotypes differed in strength of 
fluid dispenser side bias for dispensers in the HC location versus the novel location 
throughout the 10 days of self-administration. Post hoc contrasts indicated that, compared 
to +/+ and +/rl mice, the strength of bias was significantly stronger for l/rl mice, F(1, 
23) = 8.8305, p = .0068, (see Figure 4). 
 
 
 
 
 
26 
 
Nicotine (NIC) Self-administration in the Home Cage (HC) 
 NIC discrimination. To determine if NIC mice differed in drinking patterns from 
S-VEH control mice, fluid intake for HC fluid dispenser was compared to fluid intake for 
the NOVEL fluid dispenser. ANOVA, with genotype, gender, and Treatment as between 
subjects factors and trial (days 6 & 10) detected no treatment effects for NOVEL 
dispensers; however, there was a Genotype X Treatment X Trial interaction, F(2, 57) = 
3.6854, p = .0312, for HC fluid dispensers. Patterns of fluid intake for mice with NIC 
compared to S-VEH control mice differed between genotypes and treatment such that 
NIC +/+ mice increased NIC fluid intake, while S-VEH +/+ mice maintained S-VEH 
fluid intake (see Figure 5a), NIC +/rl mice decreased NIC fluid intake, while S-VEH +/rl 
mice increased S-VEH fluid intake (see Figure 5b), and NIC rl/rl mice increased NIC 
fluid intake, while S-VEH rl/rl mice increased S-VEH fluid intake (see Figure 5c). 
 Volume of NIC fluid intake. One-way ANOVA with genotype as the between-
subjects factor across repeated measures (days 1-5) revealed that total NIC intake at 30 
mg/L did not significantly differ across trials or between genotypes. However, when NIC 
concentration changed to 60 mg/L, a Genotype X Trial (days 6-10) interaction, F(8, 92) = 
2.3370, p = .0248, revealed differences in the temporal pattern of self-administration 
such that +/+ mice did not significantly change NIC intake, +/rl mice decreased NIC 
intake, and rl/rl mice increased NIC intake (see Figure 6). 
 Volume of S-VEH fluid intake for NIC mice. In addition, as shown in Figure 7, S-
VEH intake for mice with choice of NIC or S-VEH differed significantly betw en 
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genotypes, such that +/+ mice and rl/rl mice maintained consistent levels of S-VEH, 
while +/rl significantly increased S-VEH intake, F(2, 36) = 3.6120, p = .0372.  
 NIC/VEH ratio. The ratio of NIC to S-VEH differed across trials between 
genotypes when NIC concentration changed to 60 mg/L (trials 6-10), F(2, 46) = 3.2834, p 
= .0465, such that  +/rl mice significantly decreased the ratio of NIC to VEH while +/+ 
and rl/rl mice exhibited non-significant increase (see Figure 8).  
 
Social Behavior 
 Three way ANOVA with genotype , treatment (NIC, S-VEH), and gender as 
between-subjects variables and trial type (trials 1 and 2) as within-subject rep ated 
measures indicated that time in the center zone differed between genotypes fr both trials, 
F(2, 112) = 33.3215, p < .0001, with rl/rl mice spending more time in the center zone for 
each trial, p < .0001. Therefore, sociability and social recognition measures were 
analyzed by comparing proportion of time between the two end zones. Sociability was 
operationally defined as spending similar or greater proportion of time in S11 (zone with 
the stranger mouse) compared to EC (zone with empty chamber) during trial 1, using the 
formula S11/(S11 + EC). Mice exhibited sociability if proportion of time in S11 was equal 
to or greater than .50. Social recognition, operationally defined as spending less time in 
the S12 zone compared to time in the S2 zone, was calculated using the formula S12/ (S12 
+ S2). Mice exhibited social recognition if proportion of time in S12 was less than .50. 
 ANOVA with genotype (+/+, +/rl, rl/rl), treatment (NIC, VEH), and gender as 
between-subjects factors, across repeated measured (trial 1, trial 2), revealed a significant 
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Genotype X Treatment X Gender interaction, F(2, 112) = 5.3131, p = .0062,  and a 
significant Genotype X Treatment X Trial Type interaction, F(2, 112) = 6.4994, p = 
.0021. Therefore, separate analyses by gender were conducted with genotype and 
treatment as between-subjects factors for each trial type. Post hoc contrasts were 
conducted for interactions.  
     Sociability and social recognition for female mice. As shown in Figure 9, 
sociability for female VEH mice did not differ between genotypes as measur d by the 
proportion of time with S1 compared to EC. However, genotypes did differ on this 
measure depending on treatment condition, F(2 46) = 6.171, p = .0042. Post hoc 
contrasts revealed that NIC female +/rl mice spent significantly more time with S1 
compared to the EC, while NIC female r /rl mice spent less time with S1 compared to the 
EC, p = .0013. Treatment differences for female +/+ mice were not reliably different on 
this measure of sociability. 
 For the measure of social recognition during trial 2, female mice differed by 
genotype in the proportion of time with S12 (versus S2), F(2,46) = 3.4743, p = .0393, 
regardless of treatment condition. As shown in Figure 9, female +/+ and female +/rl 
mice spent proportionately less time with S12 (M = .39) compared to EC, while 
proportion of time for female rl/rl mice was .52, p = .017. Notably, while female +/+ and 
female +/rl mice spent proportionately more time with S11 (stranger mouse in trial 1) 
compared to the S12 (same mouse, now familiar) in trial 2, female rl/rl mice spent a 
similar proportion of time with S11 as with S12.  
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 Sociability and social recognition for male mice. In trial 1, male mice did not 
differ in the proportion of time spent with S11 versus EC. However, in trial 2, genotypes 
did differ on proportion of time with S12 in trial 2 depending on treatment condition, F(2, 
72) = 8.0958, p = .0007. As shown in Figure 10, male NIC +/rl mice spent less time with 
S12 compared to male VEH +/rl mice, while male NIC rl/rl mice spent more time with 
S12 compared to male VEH rl/rl mice, p = .0002. Male +/+ mice did not reliably differ 
between treatment conditions. 
 
Passive Avoidance (PA) 
 Latency for VEH mice did not differ between genotypes for the training trial, and 
latency for all genotypes increased significantly from the training trial ( l 1) to the test 
trial (trial 2), F(1,48) = 46.6796, p < .0001, which demonstrated that mice learned the 
association between entering the dark chamber and receiving a foot shock (data not 
shown). However, strength of learning for VEH mice differed between genotypes, 
F(2,117) = 5.8475, p = .0038, such that, compared to +/+ and +/rl mice, rl/rl mice 
exhibited a larger percent change in latency to enter the dark side of the test chamber 
during the test trial, p < .05 (see Figure 11). There was a significant interaction of 
Genotype X Treatment X Gender for percent change in latency, F(4, 106) = 3.3135, p = 
.0134. NIC +/+ mice tended to exhibit larger percent change in latency compared to 
VEH and MPH +/+ mice (p = .08), while NIC +/rl showed decreased percent change 
compared to VEH +/rl mice. Female MPH +/rl mice displayed significantly larger 
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percent change in latency compared to NIC and VEH female +/r  mice, p = .0084 (data 
not shown).  
 
Treatment Validation 
 For a drug to be considered effective, at a minimum, there should be significant 
effects of treatment that are consistent with predictions based on the literature, and the 
treatment effects should be evident in a number of behavioral assays in a systematic 
manner. As shown in Table 4, treatment effects were evident for both NIC and MPH. In 
the PPI trials, NIC at 6 mg/kg/BW altered PPI such that NIC mice exhibited superior PPI 
compared to VEH mice, which is consistent with the literature.  NIC at 3 mg/kg/BW did 
not reliably PPI (data not reported).  In tests of social behavior, NIC (6 mg/kg/BW via 
gavage), mice (+/rl) exhibited increased social recognition, which is also consistent with 
the literature. In NIC self-administration trials, mice altered NIC intake when NIC 
concentration increased to 60 mg/L, indicating that mice could detect NIC. However, 
additional trials at each concentration may be required in future research to determine 
maximum level of self-administration. For MPH, Pilot trials indicated 30 mg/kg/BW to 
be an effective dose in several behavioral assays. However, for PPI trials in the present 
study, MPH was used as a psychostimulant comparison in +/+ mice, and, as predicted, 
there were no effects of MPH for +/+ mice. In addition, although MPH also did not alter 
learning for +/+ mice in PA, treatment effects were evident in reelin-compromised mice. 
Thus, based on the aforementioned results, doses of NIC or MPH that were administered 
via gavage appeared to be behaviorally effective. 
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CHAPTER IV 
 
DISCUSSION 
 
 
 Recent reports of abnormal reelin-related neurobiology in individuals with 
schizophrenia, bipolar disorder, and autism have resulted in research involving reelin 
deficient mice as putative models across several domains associated with the 
aforementioned disorders. In particular, behavioral phenotypes of reelin deficient mice 
mirror several behaviors associated with schizophrenia, bipolar disorder, autism, and 
possibly ADHD, although disrupted reelin pathways have not been associated with 
ADHD. Additionally, reelin deficient mice exhibit abnormalities in cholinergic and 
dopaminergic neurotransmitter pathways, as do individuals in the aforementioned 
diagnostic categories. Thus, in the present study, behavioral phenotypes of reelin 
deficient mice were explored with the direct acetylcholine agonist nicotine (NIC), based 
in part on the observations that tobacco (and thus) nicotine is differentially used by 
individuals diagnosed with schizophrenia, bipolar disorder, autism, and ADHD. In 
addition, the effects of methylphenidate (MPH), which is a direct dopamine agonist 
prescribed for ADHD, were assessed for comparison of psychostimulant effects.  
 
Behavioral Phenotypes of +/rl and rl/rl Mice 
Table 3 summarizes behavioral phenotypes of VEH mice in the present study and 
in previous studies conducted in this lab (Salinger et al., 2003; Goode, 2006).  Consistent 
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with earlier cohorts, VEH +/rl mice exhibited enhanced acoustic startle response 
and similar performance in emotional learning in the PA test compared to VEH +/+ 
mice. However, inconsistent with earlier cohorts, +/rl mice displayed elevated PPI 
compared to +/+ mice. Also, consistent with earlier cohorts, VEH rl/rl mice exhibited 
inferior PPI compared to VEH +/+ and +/rl mice. However, compared to +/+ and +/rl 
mice in PA, rl/rl mice displayed increased percent change in latency in the test trial, 
which is not consistent with normal latency reported in VEH RISP mice.  
   
NIC-Related Improvement in PPI of +/+ and rl/rl Mice; Elevated PPI of +/rl Mice is  
 
Diminished by NIC 
 
General behavioral phenotype for ASR and PPI. Consistent with previous work 
conducted in this lab, PPI for rl/rl mice was impaired compared to +/+ and +/rl mice, and 
VEH +/rl mice exhibited elevated acoustic startle response, indicating possible 
heightened responsiveness. In addition, +/rl mice displayed elevated PPI, which is not 
consistent with previous findings in this lab (Salinger et al., 2003), or with reports of 
impaired PPI (Tueting et al., 1999), although elevated PPI in +/rl mice has been reported 
by others (Barr, Fish, Markou, & Honer, 2007). Further, elevated PPI has been reported 
in individuals diagnosed with ADHD (compared to normal control subjects and subjects 
with ADHD plus Tic disorder) (Castellanos et al., 1996), while impaired PPI has been 
associated with reelin-compromised disorders of schizophrenia, bipolar disorder, and 
autism.  
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Pharmacological effects on PPI. ASR was not reliably altered by NIC; however, 
genotypes displayed differential sensitivity to NIC in PPI. As predicted, when NIC was 
administered via gavage at 6 mg/kg/BW, PPI for NIC +/+ mice was higher compared to 
VEH +/+ mice. For NIC +/rl mice, however, PPI was diminished, and since PPI for VEH 
+/rl mice was abnormally elevated, NIC-related reduction in PPI should be taken as a 
normalizing effect. Central to predictions in the present study is evidence of impr ved 
PPI for NIC rl/rl mice compared to VEH rl/rl mice, albeit a modest effect. Taken 
together, normalization of altered PPI by NIC administration is consiste t with a 
therapeutic effect of NIC for humans diagnosed with schizophrenia. Furthermore, the 
observation that PPI and NIC effects on PPI differ in a non-linear manner (increase in 
PPI for rl/rl mice, and decrease in PPI for +/ l mice) suggest that level of reelin 
deficiency may result in altered ACh functioning. If so, differences in ACh pathways in 
reelin deficient mice may be useful for investigation of mechanisms that may be relevant 
to abnormal neurobiology and impaired sensorimotor gating associated with human 
neuropsychiatric disorders.    
  As expected, MPH did not alter PPI in +/+ mice, and MPH did not diminish 
impaired PPI of rl/rl mice, or reliably alter elevated PPI in +/rl mice. In addition, since 
MPH did alter PA learning in the present study and in pilot trials for other behavioral 
assays, the absence of an effect on PPI is not likely due to an inadequate dose—unles 
PPI is less sensitive to MPH than are other behaviors, in which case, higher doses could 
be required. However, results from this study are not inconsistent with the few r ports in 
the literature. Thus, in the present study MPH did not reliably influence impaired PPI in 
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rl/rl mice—as had been predicted—assuming that PPI deficits in rl/rl mice model those 
in schizophrenia. 
 
Abnormal S-VEH and NIC Consumption in Reelin Deficient Mice 
 General behavorial phenotype for fluid dispenser bias. While a bias for the HC 
pipette was expected in the NIC self-administration trials, and hence counterbalancing of 
HC and NOVEL fluid dispensers, the finding that rl/rl mice displayed an abnormally 
strong bias for the fluid dispenser in the HC position was not predicted. Nevertheless, this 
outcome may have implications for psychopathology. In particular, if the exaggerated 
side bias displayed by rl/rl mice reflects a preference for sameness or resistance to 
change, then rl/rl mice may model inflexible behavior (Crawley, 2007) that is associated 
with autism (American Psychiatric Association, 2000). 
 Although the fluid dispenser side bias does not solely provide evidence for 
resistance to change—which has been suggested as a measure of rigid behavior that is 
associated with autism (Crawley, 2007)—other outcomes reported in this lab may be 
useful to interpret the side bias of rl/rl mice. More specifically, in the light/dark (L/D) 
test, findings were previously reported in which, compared to +/+ and +/rl mice, rl/rl 
mice exhibited increased time in the light side of the test chamber and reduced 
exploratory transits into the enclosed dark side of the test chamber (Salinger et al, 2003; 
Goode, 2006). One possible interpretation of L/D behavior of rl/rl mice is that hey have 
an abnormally high preference for the light side of the test chamber, which could reflect 
decreased anxiety-like behavior (Crawley, 2004). Contrarily, reduced transitions into the 
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dark side exhibited by rl/rl mice could reflect resistance to explore the novel, dark side of 
the chamber since mice were previously exposed to the test chamber without the dark 
enclosure. In support of the latter explanation, a pilot group of mice tested in L/D without 
prior experience to the chamber displayed increased number of transitions into the dark 
side (Salinger & Ladrow, not published) compared to mice previously exposed to the 
chamber.  
 Furthermore, in the present study, rl/rl mice in PA did not differ in latency to 
enter the dark test chamber during the training trial, which suggests that they exhibited 
normal exploratory behavior in an environment that was not familiar to them. In addition, 
recall that in the present study, rl/rl mice displayed normal sociability when presented 
with both a novel stranger mouse and a novel inanimate object; however, when they were 
subsequently presented with a now-familiar mouse (previously the stranger mouse) and a 
second, novel mouse, rl/rl mice failed to display normal preference for novel social 
stimuli. Although impaired attention to social cues has been proposed as one possible 
mechanism underlying diminished social preference (Manrique et al., 2005), it is 
possible, that abnormal social recognition or preference exhibited by rl/rl mice in the 
present study could reflect a preference for sameness or resistance to change. 
 Arguing against the explanation of preference for sameness of HC fluid 
dispensers is that in a novel object discrimination task—in which mice were habituated o 
a novel object and then presented with a choice of a new novel or now-familiar inanimate 
object—rl/rl mice did not exhibit resistance to explore the novel object (Salinger et al, 
2003). Therefore, based on observations of an abnormally strong side bias for the HC 
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fluid dispenser, reduced exploratory behavior to a novel place in L/D, and preference for 
a familiar versus stranger mouse, additional studies are needed to determine if l/rl mice 
exhibit a preference for sameness or resistance to change. If so, rl/rl mice may model 
rigid or inflexible behavior (Crawley, 2007) that is associated with autism (Aerican 
Psychiatric Association, 2000). 
  General behavioral phenotype for fluid intake. No hypotheses were proposed for 
abnormalities in volume of fluid intake for S-VEH/S-VEH control mice. However, in the 
S-VEH/S-VEH condition, +/rl mice exhibited elevated levels of fluid intake, such that by 
the tenth and last measurement, +/rl mice drank significantly more S-VEH compared to 
+/+ mice. Similarly, S-VEH intake for rl/rl mice for the total 10-day trial was also 
elevated, although volume was less than that +/rl mice, and not significantly greater 
compared to +/+ mice. However, since mice were not provided a choice between tap 
water and S-VEH, it is not possible to determine if altered fluid intake for either genotype 
was a response to the presence of saccharin in VEH, or a reflection of impaired water 
balance regulation. Although further studies are needed, if confirmed, the excess fluid 
intake of reelin deficient mice may be of interest because of the possibility that reelin 
deficient mice may mirror abnormal fluid regulation, which has been well-documented in 
individuals with schizophrenia (de Leon, Verhgese, Tracy, Josiassen, & Simpson et al., 
1994) and may also be relevant to ADHD (Antalis et al., 2006). Conversely, if elevated 
fluid intake reflects a preference for sweetened S-VEH, findings may also be of some 
interest insofar as it has been demonstrated that rodent strains selectively bred for 
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saccharin-water preference exhibit an increased propensity for drug self-administration 
(see review, Carroll, Morgan, Anker, Perry & Dess, 2008).     
 Behavioral phenotype for NIC self-administration. Based on abnormally high 
prevalence rates of smoking associated with schizophrenia (Vanable et al., 2003) (Poirier 
et al., 2002), bipolar disorder (Hughes et al., 1986), and ADHD (Pomerleau et al., 1995), 
it was predicted that reelin deficient mice would exhibit excessive NIC self-
administration (ml/g/BW) compared to +/+ mice. Conversely, based on abnormally low 
prevalence rates of smoking associated with autism (Bejerot & Nylander, 2003)if mice 
exhibited lower NIC intake levels and/or decreased NIC intake over time compared to 
+/+ mice, then they would be viewed more appropriately as avoiding NIC as do 
individuals with autism. 
 In the present study, the observation that NIC self-administration for mice 
changed as NIC concentration increased from 30 mg/L to 60 mg/L provides evidence that 
mice detected and responded to the change in NIC concentration. In addition, although 
total NIC dosage in ml/kg/BW was not significantly different between genotypes, rl/rl 
mice increased NIC intake and maintained S-VEH intake across trials when NIC 
concentration increased to 60 mg/L, which suggests that rl/rl mice may self-administer 
NIC to a greater degree compared to +/+ and +/rl mice, given additional trials at 60 
mg/L. Conversely, +/rl mice both decreased NIC 60 mg/L intake and increased S-VEH, 
which resulted in a significantly smaller NIC/S-VEH ratio compared to +/+ and rl/rl 
mice. If the decrease in the NIC/S-VEH ratio resulted from decreases in NIC alone, 
findings would suggest that mice titrated fluids to reduce NIC intake. If, however, the 
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ratio decreased due to increased S-VEH, mice could exhibit increased preferenc  for S-
VEH, as observed with S-VEH-only +/rl mice. However, the change in NIC self-
administration among +/rl mice associated with the increase in NIC concentration from 
30 mg/L to 60  mg/L suggests that, like rl/rl mice, +/rl mice are responsive to the 
presence of NIC and modulate their intake as NIC concentration increases, but in the 
opposite direction. Thus, it appears that +/rl and rl/rl titrate their NIC intake differently, 
such that increasing NIC concentration seems to induce rl/rl mice to increase NIC 
consumption as reflected in their intake expressed in ml/kg/BW (consistent wih elevated 
NIC consumption among individuals with schizophrenia and ADHD) while apparently 
inducing +/rl mice to decrease their consumption of NIC as reflected in reductions in 
NIC dosage and in their NIC/S-VEH ratio (consistent with putatively depressed NIC 
consumption among individuals with autism). Interestingly, the observed titration 
patterns of NIC are consistent with a self-medication hypothesis in that NIC appeared to 
improve impaired PPI in rl/rl mice and diminish abnormally elevated PPI in +/rl mice in 
gavage trials. However, NIC effects on social behavior, such that NIC +/rl mice 
displayed increased social activity, while social activity of NIC rl/rl mice worsened, are 
not consistent with patterns of self-administration of NIC based on self-medication 
theories. 
 
Impaired Social Interactions in rl/rl Mice; Genotypes Differ in Response to NIC  
 General behavioral phenotype for social activity. It was hypothesized that, if mice 
displayed a preference for an inanimate stimulus versus a social stimulus, they would 
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model decreased sociability, as do individuals with schizophrenia, bipolar (depressive 
episodes), and autism (American Psychiatric Association, 2000). In addition, if mice 
displayed a preference for a recently-familiar social stimulus versus a novel social 
stimulus, they would display a lack of novel preference and, as such, model social 
recognition/memory deficits associated with schizophrenia or autism (Crawley, 2004). 
All genotypes exhibited similar patterns of sociability as evidenced by slightly greater 
proportion of time in the zone with the novel social stimulus compared to the novel 
inanimate stimulus. Thus, from this perspective, mice do not appear to exhibit abnormal 
sociability. However, for the second social dimension of social recognition/memory, 
female VEH rl/rl mice spent a greater portion of time with the now-familiar stranger 
mouse compared to the new stranger mouse, which suggests that female rl/rl mice may 
model deficits in social recognition of socially relevant stimuli, which has been proposed 
to underlie social interactions associated with schizophrenia and autism; however, sinc  
gender was not included in the model, results should be interpreted with caution and 
additional trials conducted to confirm these findings.  
 Pharmacological outcomes for social activity. As predicted, social activity for 
NIC mice differed from VEH mice, which is consistent with previously described eff cts 
of NIC on attentiveness to socially relevant cues in normal rodents (Manrique et al., 
2005), although NIC did not reliably alter social activity of +/+ mice. However, th  
observations that NIC  +/rl mice exhibited increased social interactions, while NIC rl/rl
counterparts demonstrated the reverse patterns of social behavior, suggests that for this 
behavior, degree of reelin deficiency may nonlinearly influence neurobiological 
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mechanisms that are sensitive to acetylcholine agonists. In addition, the aforementioned 
findings suggest that, while the social activity of+/rl mice does not appear to be different 
from that of wild type mice and not suitable for modeling abnormal social behavior in 
schizophrenia, bipolar disorder, or autism, NIC induced degradation of social behavior in 
rl/rl mice may reflect hypercholinergic responsiveness, which is consistent wi h 
suggestions concerning the status of individuals with autism (Lippiello, 2006).  
  
Normal PA Learning in +/rl Mice and Elevated PA Learning in rl/rl Mice   
 General behavioral phenotype for PA learning. The fourth objective of this study 
was to assess response inhibition (executive functioning) in an assay that requires animals 
to learn an association between a response (moving from a light chamber into a dark 
chamber) and an aversive stimulus (mild foot shock delivered if animal enters dark 
chamber). It was hypothesized that if reelin-deficient mice model impaired response 
inhibition associated with executive functioning deficits observed in schizophrenia and 
ADHD, then the percent change in latency to enter the dark test chamber would be 
inferior to that observed in +/+ mice. In addition, since NIC has been shown to enhance 
performance in PA (King et al., 2003), if NIC enhanced performance of +/rl mice, then 
+/rl mice would model executive functioning deficits associated with schizophrenia 
and/or ADHD. If NIC exacerbated performance, mice would support theories related to 
autism (Lippiello, 2006). Additionally, since MPH also improves tasks that require 
response inhibition in individuals with ADHD (Aron et al., 2003), if reelin deficient mice 
exhibited inferior learning in PA, and if MPH improved passive avoidance performance, 
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then mice would model impaired inhibition associated with ADHD. If on the other hand, 
MPH exacerbated performance, mice would model behavior related to reported 
deleterious effects on cognitive performance in individuals with schizophrenia (Koreen et 
al., 1997). 
 The finding that, compared to  +/+ mice, +/rl and rl/rl mice exhibited equivalent 
or elevated response inhibition in PA is not consistent with predictions of impaired 
response inhibition in reelin deficient mice as models of impaired response inhibitio  in 
individuals with schizophrenia and ADHD. Furthermore, the observation that male VEH 
rl/rl mice exhibited slightly stronger response inhibition relative to +/+ mice suggests an 
exaggerated effect of PA training. Thus, neither +/rl nor rl/rl mice displayed impaired 
response inhibition in the passive avoidance task, as had been predicted, assuming PA 
performance of rl/rl mice model response inhibition deficits in schizophrenia and/or 
ADHD.  
Pharmacological outcomes for passive avoidance. Although NIC tended to 
enhance response inhibition for +/+ mice in the PA test, which is consistent with 
predicted  enhancement of performance in PA test (King et al., 2003), it did not reliably 
increase response inhibition for any genotype. Observations of normal or elevated PA 
performance by reelin deficient mice, along with the absence of NIC effects on PA, 
suggest that +/rl and rl/rl mice do not model impaired response inhibition, as would be 
predicted if they modeled executive functioning deficits associated with schizophrenia 
and/or ADHD. In addition, although MPH gender effects were detected in the present 
study, the design of the study did not include MPH gender predictions, and as such 
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gender effects should not be considered to be interpretable.   Furthermore, an intensified 
effect of MPH on PA would be predicted if mice modeled impaired response inhibition 
associated with ADHD; however, since the reelin deficient mice acquired PA as 
effectively or more effectively that +/+ mice, their responses to MPH in the PA 
procedure cannot be taken to support the view that reelin deficient mice exhibit deficits in 
executive function that model those seen in ADHD. 
 
Reelin Deficiency in Mice is Associated with Impairments in Specific Behavioral 
Domains that Transcend Diagnostic Categories:  Implications  
 Behavioral observations, taken together with the patterns of pharmacological 
influences on mouse behaviors from the present study, suggest that behavioral features of 
reelin deficient mice do not model any one disorder:  schizophrenia, bipolar disorder, 
ADHD, and autism. Instead, the behavioral outcomes and responses of these behaviors to 
pharmacological manipulations in reelin deficient mice do suggest that degree of reelin 
disruption can result in non-linear changes in behavioral impairments. Findings of the 
present study also suggest that reelin deficiency in mice is associated w th impairments in 
specific behavioral domains that transcend diagnostic categories (see Tabl  5).  
 Reelin deficiency and altered sensorimotor gating. Deficits in PPI and differences 
in the nature of reelin disruption have been documented in schizophrenia, bipolar 
disorder, and autism. However, the relationship, if any, between differences in reelin 
disruption and sensorimotor functioning in the aforementioned pathologies has not, to my 
knowledge, been reported. However, it seems plausible that altered neurobiology as a 
 
 
43 
 
consequence of differences in reelin production could result in subtle differences in 
sensorimotor functioning. If so, reelin deficient mice may be useful to decipher altered 
underlying neurobiological mechanisms involved in sensorimotor gating across 
pathologies.   
 Reelin deficiency and impaired social behavior. Impaired social interactions are 
frequently observed in autism, as well as schizophrenia, bipolar disorder, and ADHD. 
However, the nature of social impairment varies depending on the disorder and subtype 
or phase of disorder. More specifically, social withdrawal is typically associated with 
autism spectrum disorders (American Psychiatric Association, 2000), schizophrenia 
(American Psychiatric Association, 2000; see review, Mueser & McGurk, 2004), and 
bipolar disorder during the depressive episodes (Hirschfeld, 2004). However, intrusive or 
inappropriate behavior, which has been associated with subtypes of schizophrenia 
(American Psychiatric Association, 2000), manic phases of bipolar disorder (National 
Institute of Mental Health, 2009), and hyperactive and combination subtypes of ADHD 
(American Psychiatric Association, 2000), can result in social isolation.   
 Findings of impaired social recognition or diminished preference for social 
novelty in rl/rl mice suggest that disruptions in reelin-related processes may be involved 
in underlying mechanisms associated with impaired social behavior. A putative 
underlying component of social withdrawal and isolation is impaired or altered att ntion 
to socially relevant cues (Sasson et al., 2007). However, as previously discussed, it may 
also be the case that rl/rl mice exhibit a preference for sameness or rigid, inflexible 
behavior, which results in diminished social interactions. Thus, additional studies are 
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needed to confirm social impairments in rl/rl mice and to determine underlying 
behavioral components associated with impaired social recognition. Based on the present 
observations, rl/rl mice may be useful as models of social withdrawal associated with 
neuropsychiatric disorders that include cerebral reelin deficiency as a part of their 
phenotypes. 
 Reelin deficiency and impaired executive functioning. Executive functioning is a 
construct referring to the ability to adjust and regulate behavior in response to 
environmental cues (Barkley, 1997). While schizophrenia, bipolar disorder, autism, and 
ADHD have been characterized by abnormal executive functioning, the nature of 
impairment and putative component deficits associated with impairment appear to vary
across diagnostic categories. For example, in schizophrenia, impairments involving at 
least two constructs have been identified and proposed as underlying components in 
impaired executive functioning:  (1) rule generation and selection, and (2) dynamic 
adjustments in control (Kerns, Nuechterlein, Braver, & Barch, 2008), both of which 
presumably result, in part, in impaired response inhibition. Similarly, individuals with 
ADHD, depending on subtype, have also been characterized by impaired response 
inhibition (Barkley, 1997). Executive functioning in bipolar disorder seems to be less 
defined (Balanza-Martinez et al., 2008). However, in autism, impairments in cognitive 
flexibility have been characterized as a resistance to change, rather than inability to 
inhibit responding (Russo et al., 2007).   
In the present study, reelin deficient mice did not exhibit executive functioning 
deficits of abnormal response inhibition in the PA test. However, other behaviors of rl/ l 
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mice could reflect inflexible, rigid behavior associated with psychopathologies. More 
specifically, observations of an abnormally intense bias for the HC fluid dispenser, ad 
lack of preference for a novel social stimulus versus a familiar mouse in thpresent 
study, together with observations of abnormally diminished exploratory transitions to the 
novel, dark side in light/dark test in previous research (Salinger et al., 2003) could reflect 
resistance to change. Thus, additional studies are needed in which rl/rl mice are first 
permitted to establish a stable behavior, followed by a task in which they are “asked” to 
make a change in the established behavior. If rl/rl mice exhibit a preference for sameness, 
or resistance to change, they may model rigid, inflexible behavior, which is a core deficit 
of autism (American Psychiatric Association, 2000) and a proposed animal model for 
autism (Crawley, 2007).   
 Reelin deficiency and nicotine abuse. Nicotine abuse has been well-documented 
in individuals with schizophrenia (Poirier et al., 2002; Vanable et al., 2003), bipolar 
disorder (Hughes et al., 1986), and ADHD (Pomerleau et al., 1995), but not in individuals 
with autism (Bejerot & Nylander, 2003). Furthermore, excessive use of nicotine by 
populations diagnosed with schizophrenia, bipolar disorder, and ADHD, and evidence of 
a therapeutic effect of nicotine on those individuals has led to self medication theories 
(Khantzian, 1997). Thus, in the present study, rl/rl mice exhibited impaired PPI and NIC 
related improvement in PPI, so that both the impaired PPI and its improvement under the 
influence of NIC would parallel and model impaired PPI and improvement in response to 
NIC that has been noted among individuals diagnosed with schizophrenia. If so, the 
measure of NIC-related improvement in PPI would provide both face and predictive 
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validity for the use of impaired PPI in reelin deficient mice to model that aspect of 
pathology in humans diagnosed with schizophrenia, etc. Furthermore, if rl/rl mice exhibit 
a propensity to self-administer NIC, they may also provide a model for self medication 
theories related to psychopathologies, or they may provide a model for reelin defic ency 
based models for addictive behaviors in general. 
 
Implications of Drug Effects on Behaviors of Reelin Deficient Mice:  Their Potential as 
Models of Psychopathology 
 In the present study, NIC-related improvements in PPI and PA in +/+ mice, and in
social behaviors in +/rl mice that are consistent with the literature provide treatment 
validation for NIC. Thus, observed NIC-related changes in PPI in rl/rl mice suggest that 
rl/rl mice are responsive to cholingeric agonist treatment. However, modest improvement 
of PPI in NIC rl/rl mice compared to that of +/+ mice suggest that altered neurobiology 
in rl/rl mice may involve altered metabolism of NIC, reduced availability of cholinergic 
targets in PPI circuitry, or an altered dose-response relationship in which rl/rl mice have 
a shallower slope than that for +/+ mice. Moreover, indications that rl/rl mice may self-
administer NIC, based on increased responding at 60 mg/L compared to 30 mg/L, could 
also suggest that rl/rl mice are less sensitive to NIC effects compared to +/rl and +/+ 
mice, or that they require higher concentrations of NIC. Additional trials of NIC self-
administration are needed to determine if rl/rl mice continue to self-administer NIC at 60 
mg/L, and if so, post self-administration trials of PPI could be conducted to determine 
what levels of NIC intake, if any, are optimal for PPI.  
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 Conversely, in tests of social behavior, decreased social interactions were 
observed in NIC rl/rl mice, and increased social activity in NIC +/rl mice, which 
suggests that the reelin-related alterations in the neurobiology underlying socal 
interactions are differentially influenced by NIC compared to altertions in neurobiology 
related to PPI, since the direction of NIC effects in PPI was reverse of effects on social 
behavior. It could be the case that, if NIC effects have a general ∩-shaped function 
(Picciotto, 2003), a smaller dose might have produced opposite effects on social 
behavior. However, if cholinergic neurobiology underlying social behavior in rl/rl mice 
is such that NIC degrades function, the present findings would be consistent with 
proposed theories related to cholingeric hyper-responsiveness in autism (Lippiello, 2006). 
In addition, the finding of enhanced social activity of NIC +/rl mice, compared to 
diminished effects on social activity of NIC rl/rl mice, suggests that differences in the 
level of reelin deficiency results in differential effects of NIC.  
 MPH was tested as a psychostimulant comparison for NIC, and also based on 
reports that MPH exacerbates behavior in individuals with schizophrenia. As predicted, 
MPH did not significantly improve PPI in +/+ mice. However, MPH did not further 
diminish PPI in rl/rl mice, as would be predicted if weak PPI in rl/rl mice modeled weak 
PPI associated with schizophrenia. It is possible, however, that since PPI is virtually 
absent in rl/rl mice, further degradation by MPH would be difficult to detect.  
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Conclusion 
 Observations from the present study suggest that behavioral abnormalities of 
reelin deficient mice and the responses of these abnormalities to NIC and/or MPH do not 
model those of any one disorder:  schizophrenia, bipolar disorder, autism, or ADHD. 
However, behavioral outcomes of reelin deficient mice may be relevant to one or more of 
the disorders. More specifically, rl/rl mice displayed impaired PPI and diminished social 
behavior, both of which are associated with schizophrenia, bipolar disorder, and autism, 
and all three disorders are associated with disrupted reelin pathways. In addition, when 
taken together with earlier assays, behaviors exhibited by rl/rl mice may reflect resistant 
to change, which could model rigid, inflexible behavior associated with autism. 
Furthermore, observations of impaired PPI of rl/rl mice that is improved with NIC 
administration, as observed in individuals with schizophrenia, and a propensity by rl/rl
mice to self administer NIC, may be relevant as a model of self-medication proposed in 
neuropsychiatric disorders such as schizophrenia, bipolar disorder, and ADHD 
(Khantzian, 1997). However, observations of enhanced social activity of NIC +/rl mice, 
compared to diminished effects on social activity of NIC rl/rl mice, suggests that 
differences in the level of reelin deficiency result in ACh pathways that have been altered 
in qualitatively different fashion by the quantitative differences in reelin l vels and thus, 
differences in responsiveness to NIC. Finally, elevated fluid intake exhibited y reelin 
deficient mice may be model polydipsia associated with schizophrenia or ADHD or it 
may reflect a preference for saccharin water (versus unsweetened), in which case, the 
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elevated fluid intake exhibited by reelin deficient mice may be useful as models f r 
analyzing neural processes underlying substance abuse in humans (Carroll et al., 2008).
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APPENDIX A. TABLES 
 
Table 1  
 
Behavioral and Pharmacological Effects Profiles Associated with Diagnostic Categories 
 
Note. ↑ – Elevated behavior; ↓ – Diminished behavior; ↔ – Normal behavior; NA– Not applicable; NP – No prediction 
 
Behavior Schizophrenia Bipolar Disorder Autism ADHD 
Human Animal Model NIC MPH Model NIC MPH Model NIC MPH Model NIC MPH 
Sensorimotor gating PPI ↓ ↑ ↓ ↓ ↑ NP ↓ ↓ NP ↔ ↔ or ↑ ↔ or ↓ 
Nicotine abuse NIC Self-admin ↑ NA NA ↑ NA NP ↓ NA NA ↑ NA NA 
Social interactions 
 
Sociability 
 
↓ NP NA ↓ or ↑ NP NP ↓ NP NA ↔ NA NA 
Attention - social cues 
 
Social 
recognition 
 
 
↓ 
 
↑ 
 
NA 
 
↓ 
 
↑ 
 
NP 
 
↓ 
 
↓ 
 
NA 
 
↓ or ↑ 
 
NA 
 
NA 
Executive functioning: 
Response inhibition 
 
Passive 
avoidance 
 
↓ ↑ ↓ ↓ ↑ NP NP NP NP ↓ ↑ ↑ 
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Table 2 
 
Subject Numbers by Genotype, Treatment (TX), Sex, and Behavioral Assay  
 
 
Note. Numerals to the left of slashes represent the number of f male (F) mice; numerals to the right of 
slashes represent the number of male (M) mice. NA – Not applicable 
 
 
 
 
 
 
 
 
 
 
 
  
   +/+ +/rl rl/rl 
Behavioral assay    MPH     NIC   MPH   NIC   MPH     NIC 
   (F/M)   (F/M)   (F/M)  (F/M)   (F/M)   (F/M) 
Acoustic startle & 
prepulse inhibition 
VEH 5/6 4/8 5/5 9/10 4/6 6/5 
TX 5/4 6/11 5/5 8/13 4/6 7/8 
Social behavior 
  
VEH NA 4/8 NA 9/10 NA 6/5 
TX NA 4/11 NA 8/14 NA 8/7 
Passive avoidance 
VEH 4/5 2/3 5/5 7/5 3/4 6/5 
TX 4/5 3/6 5/5 7/8 4/6 8/7 
 NIC self-administration 
VEH NA 2/3 NA 7/9 NA 6/3 
TX NA 3/6 NA 7/5 NA 8/7 
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Table 3 
 
Comparison of VEH Mice in the Present Study with Other Cohorts 
 ______________________________________________________________________ 
 
               .                                                                                                                 +/rl                                                                                                                                                                               .      .                                                                                                                 rl/rl                                                                                                                                                                 .  
 Test Measure     2003  2006 Current  2003 2006 Current 
Acoustic startle response    ↑ ↔ ↑    ↓      ↔      ↔ 
PPI % Startle Reduction    ↔  ↔  ↑      ↓       ↓        ↓ 
PA Change in latency   NA ↔       ↔  NA    ↔       ↑ 
Total fluid (VEH) intake  NA      NA       ↑  NA   NA      ↑ 
Fluid dispenser bias     NA      NA      ↔  NA   NA      ↑ 
Sociability     NA      NA      ↔  NA   NA     ↔ 
Social recognition   NA      NA      ↔  NA   NA      ↓ 
_______________________________________________________________________ 
 
Note. Significance set at p < 0.05. Arrows indicate significantly less (↓), significantly greater (↑), or no 
change (↔) compared to +/+ mice. NA indicates that either the measure was not reported or was not 
analyzed in the 2003 and 2006 studies. Note that VEH mice in the current and RISP cohorts were 
administered VEH treatments with gavage in PPI, SR, and PA trials, while all mice in trials conducted by 
Salinger et al. (2003) received no VEH/gavage treatm nt.  
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Table 4 
 
Summary of Treatment Effects 
 
Note. Significance set at p < 0.05. Arrows indicate significantly less (↓), significantly greater (↑), or no 
change (↔) compared to +/+ mice. * Indicates non-significant trend. NA – Not applicable; NP – No 
prediction 
 
 
 
 
 
 
 
 
                                        Compared to +/+   TX effect compared to respective genotype VEH 
 VEH NIC MPH 
Behavior +/rl rl/rl +/+ +/rl rl/rl +/+ +/rl rl/rl 
 
Acoustic startle 
 
↑ 
 
↔ 
 
↔ 
 
↔ 
 
↔ 
 
↔ 
 
↔ 
 
↔ 
PPI  ↑ ↓ ↑ ↓ ↑ ↔ ↔ ↔ 
NIC Self-admin 
30  mg/L 
60  mg/L 
 
NA 
NA 
 
NA 
NA 
 
 
↔ 
↔ 
 
↔ 
↓ 
 
↔ 
↑ 
 
NA 
NA 
 
NA 
NA 
 
NA 
NA 
 
Total S-VEH intake 
 
↑ 
 
↔ 
 
NA 
 
NA 
 
NA 
 
NA 
 
NA 
 
NA 
Side bias ↔ ↑ NA NA NA NA NA NA 
Sociability 
Social recognition 
      ↔ 
      ↔ 
      ↔  
       ↓ 
   ↔ 
   ↔  
   ↑ 
   ↑ 
   ↓ 
   ↓ 
  NA 
  NA 
  NA  
  NA 
  NA 
  NA 
 
Passive avoidance 
   
 
     ↔ 
 
 
       ↑ 
 
 
 *↑ 
 
   ↓ 
 
  ↔ 
 
 
    ↔ 
 
    ↑       ↑  
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Table 5 
  
Human Behaviors and Animal Behavior Assays; Behavioral Outcomes and Treatment Effects for Reelin Deficient Mice 
 
 
Note. Significance set at p < 0.05. Arrows indicate reduced (↓), elevated (↑), or no change (↔). EF – Executive function; SZ – Schizophrenia; SZA – 
Schizophrenia affective subtype; BP – Bipolar disorder; BPD – Bipolar depressive; BPM – Bipolar manic; ADHD-HC – Attention deficit hyperactivity 
disorder hyperactive and combined subtypes; ADHD-I – Attention deficit hyperactivity disorder inattentive subtype.
Altered human behaviors shared  
among psychopathologies 
Related behavior 
 in reelin-deficient mice (VEH) 
Effects of TX 
Human behavior Reduced ↔ Elevated Animal behavior   Reduced ↔ Elevated  
Startle   Acoustic startle  +/rl NIC   ↓  +/rl 
PPI 
SZ,  BPM, 
Autism 
ADHD PPI   rl/rl +/rl 
NIC   ↑ +/+    ↑ rl/rl 
NIC   ↓ +/rl 
Nicotine  abuse Autism 
SZ, BP, 
ADHD 
NIC Self-admin +/rl rl/rl 
 
Polydipsia /elevated 
thirst 
 SZ, ADHD Total fluid intake (S-VEH)  rl/rl,   +/rl  
Social interactions 
SZ, BPD, 
Autism 
ADHD-I 
SZA , BPM   
ADHD-HC 
Sociability 
  
  NIC   ↑+/rl   ↓ rl/rl 
Social cognition 
(attn to cues) 
SZ, Autism 
ADHD 
 Social recognition rl/rl  NIC   ↑ +/rl   ↓ rl/rl 
EF: Response inhibition SZ, ADHD  Passive avoidance  rl/rl MPH ↑ +/rl  ↑ rl/rl 
EF: Inflexible   behavior   Autism Fluid dispenser ide bias  rl/rl  
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APPENDIX B. FIGURES 
 
 
 
 
Figure 1. Acoustic startle response (+SE) for VEH mice. Compared to +/+ and rl/rl 
mice, +/rl mice exhibited increased startle amplitude, p < .01; Male mice exhibited 
increased startle amplitude compared to female mice, p = .0150. 
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a 
 
b 
 
 
Figure 2. Prepulse inhibition (PPI) of startle. Mean amplitude reduction in acoustic startle 
response (+SE). Figure 2a shows PPI for rl/rl mice was inferior to +/+ mice, p < .0001, 
and NIC +/+ and NIC rl/rl mice exhibited increased PPI compared to MPH and VEH 
mice, p < .01. In Figure 2b, NIC +/rl mice exhibited decreased % PPI compared to VEH 
+/rl mice, p = .05.  
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Figure 3. Saccharin vehicle (S-VEH) intake. In a control group of mice in which two 
fluid dispensers containing S-VEH (S-VEH/S-VEH) were presented, total S-VEH levels 
tended to differ between genotypes,  p = .1170, with higher S-VEH intake for +/rl mice, 
p < .05, compared to +/+, and levels that increased over time for +/rl and rl/rl mice.  
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Figure 4. Fluid dispenser position bias. Genotypes differed in the proportion of fluid 
intake from HC dispensers compared to fluid dispensers in the novel position, p < .05. 
While all mice exhibited a bias for HC fluid dispensers, strength of bias was significantly 
greater for rl/rl mice compared to +/rl and +/+ mice, p = .0068.  
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Figure 5. NIC and S-VEH self-administration. Changes in NIC 60 mg/L intake for fluid 
dispensers in HC position indicate that mice could discriminate change in concentration 
from 30 mg/L to 60 mg/L. (a) +/+ mice increased NIC and maintained S-VEH fluid 
intake. (b) +/rl mice decreased NIC and increased S-VEH. (c) rl/rl mice increased both 
NIC and S-VEH. 
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Figure 6. NIC intake in fluid choice condition. Genotypes did not differ in total 
ml/kg/BW of self-administration NIC. However, at 60 mg/L, +/rl mice decreased NIC 
intake compared to intake when NIC was available at 30 mg/L, while rl/rl mice increased 
NIC intake, p < .05.  
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Figure 7. S-VEH intake in fluid choice condition. +/rl mice with choice of NIC and S-
VEH significantly increased intake across trials, p < .05, while +/+ and rl/rl mice 
maintained level of S-VEH intake across trials. 
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Figure 8. Ratio of NIC/S-VEH. +/rl mice decreased NIC/S-VEH ratio from trial days 6-
10, while +/+ and rl/rl mice maintained NIC/S-VEH ratio across trials.
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Figure 9. Social activity for female mice. In Trial 1, sociability was defined as the 
proportion of time with stranger mouse (S1) versus empty chamber (EC) calculated as 
S1/(EC+S), where higher proportion time reflected greater sociability. Female NIC +/rl 
mice spent a larger proportion of time with S1 compared to VEH +/rl mice, while female 
NIC rl/rl mice tended to spend proportionately less time with S1 compared to female 
VEH rl/rl mice, p = .0013. In Trial 2, social recognition was defined as the proportion of 
time with now-familiar mouse (S12) versus new stranger mouse (S2) calculated as S12/ 
(S12 + S2), where lower proportion time with S12 reflected higher degree of social 
recognition or memory. Female rl/rl mice spent proportionately more time with S12 
compared to female +/rl and +/+ mice, p = .017.  
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Figure 10. Social activity for male mice. In Trial 1, sociability was defined as the 
proportion of time with stranger mouse (S1) versus empty chamber (EC) calculated as 
S1/(EC+S), where higher proportion time reflected greater sociability. Male genotypes 
did not differ by genotype or treatment. In Trial 2, social recognition was defined as the 
proportion of time with now-familiar mouse (S12) versus new stranger mouse (S2) 
calculated as S12/ (S12 + S2), where lower proportion time with S12 reflected higher 
degree of social recognition or memory. Male NIC +/rl mice spent less time in S12 zone 
compared to Male VEH +/rl mice, while male NIC rl/rl mice spent more time in S12 
compared to male VEH rl/rl mice, p = .0002. 
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Figure 11. Response inhibition in PA test. Latency to enter the test chamber significantly 
increased for all VEH genotypes from trial 1 to trial 2 (expressed as % change), although 
the strength of % change was greater for VEH rl/rl mice compared to +/+ and +/rl mice, 
p = .03. NIC +/rl mice exhibited smaller % change compared to MPH and VEH mice, p 
= .0314, while NIC +/+ mice exhibited greater % change compared to MPH and VEH 
mice, p = .05.  
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